News|Events|January 9, 2025
OPT Congress: Oligonucleotide & mRNA Therapeutics: March 11–12, 2025
Author(s)BioPharm International Editors
This event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists, and technology providers to discuss advances in next-generation therapeutics.
Dates: March 11–12, 2025
Location: Seaport Hotel, Boston, Mass. & Virtual
Description: This event brings together leading chemists, biologists, toxicologists, CMC experts, regulatory specialists, and technology providers to discuss advances in next-generation therapeutics.
Registration:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
WHO Finalizes United States’ Withdrawal from Organization: Report
4
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
5